The medical landscape for diabetes is shifting, and transdermal GLP-1 delivery systems represent a promising advance. Unlike subcutaneous injections, this method offers a simpler way to deliver GLP-1 drugs. These https://nicolasoeek856967.ssnblog.com/39642169/glp-1-patches-a-new-approach-to-glucose-management